Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
VolitionRx reports net loss of $1.9 million for second quarter 2015

VolitionRx reports net loss of $1.9 million for second quarter 2015

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

CRI commits $29.3 million in new funds to accelerate development of cancer immunotherapies

High levels of specific proteins in urine can accurately detect early-stage pancreatic cancer

High levels of specific proteins in urine can accurately detect early-stage pancreatic cancer

BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical School

BRCA gene mutations and ovarian cancer: an interview with Dr Matulonis, Harvard Medical School

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Eisai, Halozyme partner to evaluate eribulin and PEGPH20 in HER2-negative metastatic breast cancer

Study: Omega-3 fatty acids may help improve treatment response, quality of life for patients with cancer

Study: Omega-3 fatty acids may help improve treatment response, quality of life for patients with cancer

New paper describes positive effects of CRAC channel inhibitors in animal models of acute pancreatitis

New paper describes positive effects of CRAC channel inhibitors in animal models of acute pancreatitis

Study examines link between use of diabetes drug pioglitazone and increased risk of bladder cancer

Study examines link between use of diabetes drug pioglitazone and increased risk of bladder cancer

UCLA scientists identify new method to deliver glucose to pancreatic and prostate cancer cells

UCLA scientists identify new method to deliver glucose to pancreatic and prostate cancer cells

NeoGenomics announces launch of new germline cancer predisposition testing services

NeoGenomics announces launch of new germline cancer predisposition testing services

Magnetic nanoparticles may hold key to bringing immunotherapy into successful clinical use

Magnetic nanoparticles may hold key to bringing immunotherapy into successful clinical use

Canadian researchers launch world's first viral therapy clinical trial to attack and kill cancer cells

Canadian researchers launch world's first viral therapy clinical trial to attack and kill cancer cells

Researchers develop novel technique to generate activated T cells to tackle advanced melanoma

Researchers develop novel technique to generate activated T cells to tackle advanced melanoma

Researchers identify better way to screen for lung cancer

Researchers identify better way to screen for lung cancer

CTCA at Western begins Phase Ib/II trial of new immunotherapy treatment for cancer patients

CTCA at Western begins Phase Ib/II trial of new immunotherapy treatment for cancer patients

IU researchers find that microRNA-29 may be potent therapeutic target against pancreatic cancer

IU researchers find that microRNA-29 may be potent therapeutic target against pancreatic cancer

New chemical compound reduces pancreatic cancer tumour growth by 80% in mice

New chemical compound reduces pancreatic cancer tumour growth by 80% in mice

Gene-encoded protein may be effective in early detection of pancreatic cancer

Gene-encoded protein may be effective in early detection of pancreatic cancer

Johns Hopkins researchers identify multiple genetic changes that may increase risk of pancreatic cancer

Johns Hopkins researchers identify multiple genetic changes that may increase risk of pancreatic cancer

Study suggests that blood clots in abdominal vein could be an indicator of undiagnosed cancer

Study suggests that blood clots in abdominal vein could be an indicator of undiagnosed cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.